Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20131
20152
20162
20171
20191
20202
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Incyte Corporation3
Gilead Sciences2
Astellas Pharma Inc1
Bristol-Myers Squibb1
Celgene1
Drugs for Neglected Diseases1
Fundación Teófilo Hernando, Spain1
Sanofi1
Syndax Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome18
Leukemia4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Chronic Urticaria2
Graft vs Host Disease2
Urticaria2
Bone Marrow Diseases1
Bronchiolitis Obliterans1
Carcinoma, Hepatocellular1
Chagas Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.